Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

Elizabeth R. Tucker, Irène Jiménez, Lindi Chen, +32

Clinical Cancer Research

The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples

Ruben Van Paemel, Charlotte Vandeputte, Lennart Raman, +23

European Journal of Cancer

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study

Olivia Ruhen, Nathalie S.M. Lak, Janine Stutterheim, +33

JCO Precision Oncology

Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma

Nathalie S.M. Lak, Lieke M. J. van Zogchel, Lily Zappeij‐Kannegieter, +16

JCO Precision Oncology

Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving <i>ALK</i> -Targeted Therapy

Charles Bobin, Yasmine Iddir, Charlotte Butterworth, +31

Clinical Cancer Research

A SPRY1 domain cardiac ryanodine receptor variant associated with short-coupled torsade de pointes

Zahia Touat-Hamici, Malorie Blancard, Ruifang Ma, +6

Scientific Reports

Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors

Mathieu Chicard, Yasmine Iddir, Julien Masliah‐Planchon, +16

Cancers